Supervisor Wiener: Reclassifying HIV Drugs as “Specialty” is Discriminatory
A hearing held on March 25, 2015 at a San Francisco City and County Budget and Finance Committee called attention to the insurance company practice of reclassifying HIV medications as … Read More →
View ArticleCapping Coinsurance Payments for PrEP and HIV Meds
Covered California is now deliberating caps to the costs that patients pay for specialty prescription drugs. In May, the health insurance exchange’s board will vote on a recommendation made by … Read...
View ArticleSix Must-Ask Questions for Your Provider When Starting a New HIV Medication
If you’ve been living with HIV for a while, or even if you’re newly diagnosed, you probably know that there are a multitude of HIV medications—antiretrovirals—on the market. By my … Read More →
View ArticleGenvoya: A New Once-Daily Combo HIV Medication
Yesterday, the U.S. Food and Drug Administration (FDA) announced that it has approved an updated version of Stribild that will deliver the same antiviral effects but at a lower dose. … Read More →
View ArticleStudy: Protease Inhibitor Monotherapy Does Not Limit Future Treatment Options
A recent study published in The Lancet HIV provides evidence that HIV maintenance therapy with a provider-selected boosted protease inhibitor (PI) regimen does not increase the risk of drug resistance...
View ArticleStart—and continue—HIV meds as soon as you can
Sometimes, people who have just been diagnosed with HIV ask me when they need to start taking HIV medications. If you’re living with HIV, you probably have heard that it’s … Read More →
View ArticleOdefsey: New HIV Combination Pill is More Gentle on Bones, Kidneys
The FDA has approved a new once-daily drug regimen for the treatment of HIV. Odefsey, by Gilead Sciences, is composed of emtricitabine (200 mg), rilpivirine (25 mg), and tenofovir alafenamide … Read...
View ArticleAsk A Pharmacist: With a new tenofovir, should you switch to Descovy, Genvoya...
Many people living with HIV may be familiar with an HIV medication called tenofovir. Tenofovir disoproxil fumarate (brand name Viread, and also known as “TDF”) is an NRTI. It is … Read More →
View ArticleDon’t let problems with ADAP prevent you from getting HIV meds
This past summer, the AIDS Drug Assistance Program (ADAP) in California underwent some big changes—resulting in frustrations for clients in the ADAP system, in addition to enrollment workers,...
View ArticleDon’t use poppers with Viagra, and other critical drug interaction advice
Twice a month, the San Francisco AIDS Foundation program Positive Force hosts free The Dr. Is In events for people living with HIV in our community. Dr. Neal Sheran, the … Read More →
View Article
More Pages to Explore .....